Showing results (431-440 of 892) with videos related to
Sort By:
Pageof 90
Journal of Pediatric Hematology/Oncology|April 22, 2021
Use of Pharmacologic Prophylaxis Against Venous Thromboembolism in Hospitalized Injured ChildrenArash Mahajerin, John K Petty, Sheila J Hanson, et al.Journal of Pediatric Surgery|July 28, 2020
Risks of venous thrombosis and bleeding in critically ill adolescents after trauma or major surgerySheila J Hanson, Arash Mahajerin, John K Petty, et al.The Analysis of Verbal Behavior|July 4, 2024
Correspondence Between Vocal-Verbal Behavior and Go/No-Go Responses During the Successive Matching-to-Sample ProcedureJillian C Sordello, Robbie J Hanson, Caio F Miguel, et al.The American Journal of Cardiology|December 15, 1995
Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery diseaseC S Barr, C C Lang, J Hanson, et al.Irish Journal of Medical Science|August 1, 1989
Living related renal transplantation in Ireland: a sixteen year reviewY O'Meara, A Green, J Donohoe, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 27, 1999
Edmonton Regional Palliative Care Program: impact on patterns of terminal cancer careE Bruera, C M Neumann, B Gagnon, et al.Journal of Animal Science|May 16, 2006
Correlated responses in growth, carcass, and meat quality traits to divergent selection for testosterone production in pigsJ M Bender, M T See, D J Hanson, et al.Archives of Biochemistry and Biophysics|March 12, 2010
Extracellular hydrophobic regions in scavenger receptor BI play a key role in mediating HDL-cholesterol transportGabriella A Papale, Kay Nicholson, Paul J Hanson, et al.Metabolomics : Official Journal of the Metabolomic Society|December 14, 2019
Cerebrospinal fluid lipidomics: effects of an intravenous triglyceride infusion and apoE statusAngela J Hanson, William A Banks, Lisa F Bettcher, et al.Prostaglandins & Other Lipid Mediators|July 24, 2007
BM-520, an original TXA2 modulator, inhibits the action of thromboxane A2 and 8-iso-prostaglandin F2alphain vitro and in vivo on human and rodent platelets, and aortic vascular smooth muscles from rodentsS Rolin, J Hanson, C Vastersaegher, et al.Pageof 90